JPRN-UMIN000049186
Not Yet Recruiting
N/A
Exploratory research of biomarkers for investigational drugs using tear fluid samples - Exploratory research of biomarkers for investigational drugs using tear fluid samples
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Santen Pharmaceutical Co. Ltd.
- Enrollment
- 29
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects who were unable to calculate the ratio of pre\- and post\-treatment expression level due to the absence of either sample or subjects who withdrew their consent to opt\-out.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Exploratory study to investigate biomarkers associated with pathogenesis of infantile hemangioma.Infantile hemangiomaJPRN-UMIN000038574Wakayama Medical University45
Completed
N/A
The exploratory study to evaluate biomarkers in prospective multicenter observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer or extensive disease small cell lung cancer (J-TAIL-2)on-small cell lung cancer or extensive disease small cell lung cancerJPRN-UMIN000043663CHUGAI PHARMACEUTICAL CO., LTD.450
Recruiting
N/A
An exploratory prospective study of the biomarkers of the immune-related adverse events (irAE) and the mechanisms of irAE in solid cancer patients treated with Pembrolizumab.solid cancerJPRN-UMIN000028474Department of Internal Medicine, Division of Medical Oncology, Showa University School of Medicine.30
Recruiting
N/A
An exploratoly study to evaluate biomarkers in cell free DNA of "Sequential therapy from afatinib to osimertinib for EGFR mutant non small cell lung cancer: a multicenter prospective observational study (Gio Tag Japan)".non-small cell lung cancer(EGFR mutation positive)JPRN-UMIN000043235HANSHIN Oncology Group93
Completed
N/A
Prospective research of the biomarkers associated with adjuvant chemotherapy in patients with resectable biliary tract cancerBiliary tract cancerJPRN-UMIN000004613Department of Medical Oncology, University of Miyazaki Hospital50